Journal Mobile Options
Table of Contents
Vol. 85, No. 1, 2004
Issue release date: March 2004
Biol Neonate 2004;85:55–60
(DOI:10.1159/000074959)

Imbalanced Cytokine Secretion in Newborns

Kotiranta-Ainamo A. · Rautonen J. · Rautonen N.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

In adults, a balance between Th1 and Th2 cytokine networks has been proposed to be associated with a healthy status. Newborn babies are reported to express Th2-type immune reactions. Further, the impaired protection of newborn babies against infections has been attributed to a deficient secretion of interferon gamma (IFN-γ) and interleukin-10 (IL-10). Using IFN-γ and IL-10 as surrogate markers of Th1 and Th2 orientation, we compared the patterns of IFN-γ and IL-10 secretion by peripheral blood mononuclear cells between 52 healthy newborns and 35 adults. The baseline secretion of IFN-γ in adults was similar to that of newborns. The lipopolysaccharide-stimulated IFN-γ secretion was higher in newborns than in adults, whereas the concanavalin-A-stimulated IFN-γ secretion was higher in adults. The unstimulated and stimulated IL-10 secretion was significantly lower in newborns than in adults. Using a threshold level of 1,000 pg/ml, we classified neonates and adults on the basis of their stimulated IL-10 and IFN-γ secretion. Four different groups were identified: IL-10-oriented secretion, IFN-γ- oriented secretion, balanced high secretion, and balanced low secretion. Only 25% of the neonates had a high IL-10 and a high IFN-γ secretion as compared with 77% of the adults. Eight percent of the newborns, but none of the adults, had a low secretion of both cytokines. Thirty-six percent of the neonates, but only 5% of the adults, had a high IL-10 and a low IFN-γ secretion. Thirty-one percent of the neonates and 18% of the adults had a high IFN-γ secretion, but a low IL-10 secretion. We conclude that neonates have an immature IL-10 and IFN-γ response as compared with adults. However, individual neonates may have a mature cytokine secretion, whereas others may have a Th1- or a Th2-directed immune response.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Gallucci S, Lolkema M, Matzinger P: Natural adjuvants: Endogenous activators of dendritic cells. Nat Med 1999;5:1249–1255.
  2. Spellberg B, Edwards JE: Type 1/type 2 immunity in infectious diseases. Clin Infect Dis 2001;32:76–102.
  3. Adorini L, Guery JC, Trembleau S: Manipulation of the Th1/Th2 cell balance: An approach to treat human autoimmune diseases? Autoimmunity 1996;23:53–68.
  4. Segal BM, Dwyer BK, Shevach EM: An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J Exp Med 1998;187:537–546.
  5. Wierenga EA, Snoek M, de Groot C, Chretien I, Bos JD, Jansen HM, Kapsenberg ML: Evidence for compartmentalization of functional subsets of CD4+ T lymphocytes in atopic patients. J Immunol 1990;144:4651–4656.
  6. Koning H, Baert MR, Oranje AP, Savelkoul HF, Neijens HJ: Development of immune functions related to allergic mechanisms in young children. Pediatr Res 1996;40:363–375.
  7. Abrams JS, Roncarolo MG, Yssel H, Andersson U, Gleich GJ, Silver JE: Strategies of anti-cytokine monoclonal antibody development: Immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev 1992;127:5–24.
  8. Muller K, Zak M, Nielsen S, Pedersen FK, de Nully P, Bendtzen K: In vitro cytokine production and phenotype expression by blood mononuclear cells from umbilical cords, children and adults. Pediatr Allergy Immunol 1996;7:117–124.
  9. Chomarat P, Rissoan MC, Banchereau J, Miossec P: Interferon gamma inhibits interleukin 10 production by monocytes. J Exp Med 1993;177:523–527.
  10. Komatsu N, Shichijo S, Maeda Y, Itoh K: Measurement of interferon-gamma by high-throughput fluorometric microvolume assay technology system. J Immunol Methods 2002;263:169–176.
  11. Lewis DB, Larsen A, Wilson CB: Reduced interferon-gamma mRNA levels in human neonates: Evidence for an intrinsic T cell deficiency independent of other genes involved in T cell activation. J Exp Med 1986;163:1018–1023.
  12. Wilson CB, Westall J, Johnston L, Lewis DB, Dower SK, Alpert AR: Decreased production of interferon-gamma by human neonatal cells: Intrinsic and regulatory deficiencies. J Clin Invest 1986;77:860–867.
  13. Tang ML, Kemp AS, Thorburn J, Hill DJ: Reduced interferon-gamma secretion in neonates and subsequent atopy. Lancet 1994;344:983–985.
  14. Trivedi HN, HayGlass KT, Gangur V, Allardice JG, Embree JE, Plummer FA: Analysis of neonatal T cell and antigen presenting cell functions. Hum Immunol 1997;57:69–79.

    External Resources

  15. Kotiranta-Ainamo A, Rautonen J, Rautonen N: Interleukin-10 production by cord blood mononuclear cells. Pediatr Res 1997;41:110–113.
  16. Holt PG: Immunoregulation of the allergic reaction in the respiratory tract. Eur Respir J Suppl 1996;22:85–89.
  17. Donckier V, Flamand V, Desalle F, Vanderhaeghen ML, de Veerman M, Thielemans K, Abramowicz D, Goldman M: IL-12 prevents neonatal induction of transplantation tolerance in mice. Eur J Immunol 1998;28:1426–1430.
  18. Delespesse G, Yang LP, Ohshima Y, Demeure C, Shu U, Byun DG, Sarfati M: Maturation of human neonatal CD4+ and CD8+ T lymphocytes into Th1/Th2 effectors. Vaccine 1998;16:1415–1419.
  19. Ridge JP, Fuchs EJ, Matzinger P: Neonatal tolerance revisited: Turning on newborn T cells with dendritic cells. Science 1996;271:1723–1726.
  20. Langrish CL, Buddle JC, Thrasher AJ, Goldblatt D: Neonatal dendritic cells are intrinsically biased against Th-1 immune responses. Clin Exp Immunol 2002;128:118–123.
  21. Marshall-Clarke I, Reen I, Tasker I, Hassan I: Neonatal immunity: How well has it grown up? Immunol Today 2000;21:35–41.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50